{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:02:57Z","timestamp":1761854577362,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.medcli.2019.01.013","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T09:18:48Z","timestamp":1550913528000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Actualizaci\u00f3n en el estado de mal epil\u00e9ptico (status epilepticus)"],"prefix":"10.1016","volume":"153","author":[{"given":"Estevo","family":"Santamarina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Abraira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2019.01.013_bib0235","first-page":"650","article-title":"Status epilepticus in adults","volume":"72","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","article-title":"Incidence and mortality of super-refractory status epilepticus in adults","volume":"49","author":"Kantanen","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.medcli.2019.01.013_bib0245","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1528-1157.1970.tb03871.x","article-title":"Clinical and electroencephalographical classification of epileptic seizures","volume":"11","author":"Gastaut","year":"1970","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0250","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","article-title":"It's time to revise the definition of status epilepticus","volume":"40","author":"Lowenstein","year":"1999","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0255","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0260","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1212\/WNL.0000000000004147","article-title":"Emergency response to out-of-hospital status epilepticus: A 10-year observational cohort study","volume":"89","author":"Semmlack","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.01.013_bib0265","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1474-4422(16)30137-5","article-title":"Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study","volume":"15","author":"Leitinger","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0270","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WCO.0000000000000307","article-title":"Recent advances in status epilepticus","volume":"29","author":"Trinka","year":"2016","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0275","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs."},{"key":"10.1016\/j.medcli.2019.01.013_bib0280","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2019.01.013_bib0285","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003723.pub3","article-title":"Anticonvulsant therapy for status epilepticus","author":"Prasad","year":"2014","journal-title":"Cochrane database Syst Rev."},{"key":"10.1016\/j.medcli.2019.01.013_bib0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2016.09.020","article-title":"Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.medcli.2019.01.013_bib0295","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2019.01.013_bib0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40263-015-0271-x","article-title":"A common reference-based indirect comparison meta-analysis of buccal versus intranasal midazolam for early status epilepticus","volume":"29","author":"Brigo","year":"2015","journal-title":"CNS Drugs."},{"key":"10.1016\/j.medcli.2019.01.013_bib0305","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Yasiry","year":"2014","journal-title":"Seizure."},{"issue":"Suppl. 6","key":"10.1016\/j.medcli.2019.01.013_bib0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12288","article-title":"The established status epilepticus trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0315","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/epi.13716","article-title":"Lacosamide in status epilepticus: systematic review of current evidence","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0320","article-title":"Timing in the treatment of status epilepticus: from basics to the clinic","author":"Ga\u00ednza-Lein","year":"2018","journal-title":"Seizure."},{"key":"10.1016\/j.medcli.2019.01.013_bib0325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yebeh.2018.04.025","article-title":"Intravenous lacosamide (LCM) in status epilepticus (SE): weight-adjusted dose and efficacy","volume":"84","author":"Santamarina","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.medcli.2019.01.013_bib0330","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0335","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.medcli.2019.01.013_bib0340","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.medcli.2019.01.013_bib0345","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-016-0371-2","article-title":"(S)-ketamine in refractory and super-refractory status epilepticus: a retrospective study","volume":"30","author":"H\u00f6fler","year":"2016","journal-title":"CNS Drugs."},{"key":"10.1016\/j.medcli.2019.01.013_bib0350","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","article-title":"Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study","volume":"82","author":"Sutter","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.01.013_bib0355","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yebeh.2018.07.004","article-title":"Perampanel in the treatment of status epilepticus: a systematic review of the literature","volume":"86","author":"Brigo","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.medcli.2019.01.013_bib0360","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yebeh.2017.03.028","article-title":"Treatment of refractory and super-refractory status epilepticus with brivaracetam: a cohort study from two German university hospitals","volume":"70","author":"Strzelczyk","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"Suppl. 2","key":"10.1016\/j.medcli.2019.01.013_bib0365","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/epi.14486","article-title":"Intravenous brivaracetam in status epilepticus: a retrospective single-center study","volume":"59","author":"Kalss","year":"2018","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0370","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/brain\/aws091","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Ferlisi","year":"2012","journal-title":"Brain."},{"key":"10.1016\/j.medcli.2019.01.013_bib0375","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0380","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0385","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/14737175.2014.956457","article-title":"Autoimmunity and inflammation in status epilepticus: from concepts to therapies","volume":"14","author":"Holzer","year":"2014","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.medcli.2019.01.013_bib0390","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yebeh.2015.04.054","article-title":"New-onset refractory status epilepticus (NORSE) - The potential role for immunotherapy","volume":"47","author":"Khawaja","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.medcli.2019.01.013_bib0395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care."},{"key":"10.1016\/j.medcli.2019.01.013_bib0400","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain."},{"issue":"Suppl. 6","key":"10.1016\/j.medcli.2019.01.013_bib0405","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/epi.12289","article-title":"Neuroactive steroids for the treatment of status epilepticus","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0410","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.25008","article-title":"Brexanolone as adjunctive therapy in super-refractory status epilepticus","volume":"82","author":"Rosenthal","year":"2017","journal-title":"Ann Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0415","unstructured":"Sage Therapeutics. (2017, September 12). Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus [Press release]. 2017."},{"key":"10.1016\/j.medcli.2019.01.013_bib0420","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1994.tb02908.x","article-title":"Determinants of mortality in status epilepticus","volume":"35","author":"Towne","year":"1994","journal-title":"Epilepsia."},{"key":"10.1016\/j.medcli.2019.01.013_bib0430","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2019.01.013_bib0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2010.09.003","article-title":"Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review","volume":"93","author":"Neligan","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.medcli.2019.01.013_bib0440","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jns.2016.10.004","article-title":"Latency to treatment of status epilepticus is associated with mortality and functional status","volume":"370","author":"Cheng","year":"2016","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.medcli.2019.01.013_bib0445","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2015.04.059","article-title":"Prognosis of status epilepticus (SE): relationship between SE duration and subsequent development of epilepsy","volume":"49","author":"Santamarina","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.medcli.2019.01.013_bib0450","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy","volume":"255","author":"Rossetti","year":"2008","journal-title":"J Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0455","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/ene.13073","article-title":"A new clinical score for the prognosis of status epilepticus in adults","volume":"23","author":"Gonz\u00e1lez-Cuevas","year":"2016","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.medcli.2019.01.013_bib0460","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12028-014-0080-y","article-title":"Epidemiology-based mortality score in status epilepticus (EMSE)","volume":"22","author":"Leitinger","year":"2015","journal-title":"Neurocrit Care."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775319300594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775319300594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:50:18Z","timestamp":1758419418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775319300594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0025775319300594"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2019.01.013","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualizaci\u00f3n en el estado de mal epil\u00e9ptico (status epilepticus)","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2019.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}